411 related articles for article (PubMed ID: 29122155)
21. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
22. Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens.
Maciag MC; Ward SL; O'Connell AE; Broyles AD
Ann Allergy Asthma Immunol; 2020 Jun; 124(6):589-593. PubMed ID: 32087343
[TBL] [Abstract][Full Text] [Related]
23. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
Picard M; Galvão VR
J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
[TBL] [Abstract][Full Text] [Related]
24. Desensitization for drug allergy.
Castells M
Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):476-81. PubMed ID: 17088655
[TBL] [Abstract][Full Text] [Related]
25. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.
Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M
J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal Antibodies Hypersensitivity: Prevalence and Management.
Santos RB; Galvão VR
Immunol Allergy Clin North Am; 2017 Nov; 37(4):695-711. PubMed ID: 28965635
[TBL] [Abstract][Full Text] [Related]
27. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
[TBL] [Abstract][Full Text] [Related]
28. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
29. Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis.
V Villarreal-González R; E de Lira-Quezada C; N González-Díaz S; L Carrasco-Díaz L; González-Llano O
J Oncol Pharm Pract; 2021 Apr; 27(3):747-750. PubMed ID: 32787558
[TBL] [Abstract][Full Text] [Related]
30. A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.
Madrigal-Burgaleta R; Bernal-Rubio L; Berges-Gimeno MP; Carpio-Escalona LV; Gehlhaar P; Alvarez-Cuesta E
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):618-632. PubMed ID: 30098410
[TBL] [Abstract][Full Text] [Related]
31. Successful desensitization with chemotherapeutic drugs: a tertiary care center experience.
Çakmak ME; Kaya SB; Can Bostan Ö; Öztürk Aktaş Ö; Damadoğlu E; Karakaya G; Kalyoncu AF
Eur Ann Allergy Clin Immunol; 2022 Mar; 54(2):90-94. PubMed ID: 33944541
[No Abstract] [Full Text] [Related]
32. Pediatric Drug Hypersensitivity.
Rukasin CRF; Norton AE; Broyles AD
Curr Allergy Asthma Rep; 2019 Feb; 19(2):11. PubMed ID: 30793223
[TBL] [Abstract][Full Text] [Related]
33. Presentation and management of the delayed type of hypersensitivity reaction with bendamustine.
Shikdar S; Totton D; Turco T; Rachshtut M
Anticancer Drugs; 2018 Sep; 29(8):814-816. PubMed ID: 29877929
[TBL] [Abstract][Full Text] [Related]
34. Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.
Görgülü B; Seval GC; Kendirlinan R; Toprak SK; Özcan M; Bavbek S
J Investig Allergol Clin Immunol; 2019; 29(6):468-470. PubMed ID: 31530515
[No Abstract] [Full Text] [Related]
35. Opioid Hypersensitivity: Predictors of Allergy and Role of Drug Provocation Testing.
Li PH; Ue KL; Wagner A; Rutkowski R; Rutkowski K
J Allergy Clin Immunol Pract; 2017; 5(6):1601-1606. PubMed ID: 28550985
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic desensitization for the allergic patient: 5 years of experience and practice.
Turvey SE; Cronin B; Arnold AD; Dioun AF
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):426-32. PubMed ID: 15104194
[TBL] [Abstract][Full Text] [Related]
37. Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity.
Cortellini G; Romano A; Santucci A; Barbaud A; Bavbek S; Bignardi D; Blanca M; Bonadonna P; Costantino MT; Laguna JJ; Lombardo C; Losappio LM; Makowska J; Nakonechna A; Quercia O; Pastorello EA; Patella V; Terreehorst I; Testi S; Cernadas JR; ; Dionicio Elera J; Lippolis D; Voltolini S; Grosseto D
Allergy; 2017 Mar; 72(3):498-506. PubMed ID: 27732743
[TBL] [Abstract][Full Text] [Related]
38. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
Castells M
Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
[TBL] [Abstract][Full Text] [Related]
39. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
[TBL] [Abstract][Full Text] [Related]
40. Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin.
Silver J; Garcia-Neuer M; Lynch DM; Pasaoglu G; Sloane DE; Castells M
J Allergy Clin Immunol Pract; 2020 May; 8(5):1668-1680.e2. PubMed ID: 32112926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
